Patent ID: 6897229

Claim:
A commercial pharmaceutical product, consisting of a secondary pack that contains a primary pack containing the medicament and, optionally a pack insert, the medicament containing as active compound N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluorornethoxybenzamide, a pharmacologically tolerable salt or the N-oxide thereof, wherein in that on the secondary pack, and/or on the pack insert, is indicated that N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-ditluoromethoxybenzamide, a pharmacologically tolerable salt or the N-oxide thereof, is used in combination with a PDE3 inhibitor in the therapeutic treatment of disease conditions which are based on acute or chronic obstruction of vessels and/or bronchi and/or on acute or chronic inflammation.